| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,391 | 22,370 | 25,900 | 27,343 | | Cost of Revenue | 10,979 | 13,338 | 15,285 | 15,728 | | | Gross Profit | 6,412 | 9,032 | 10,615 | 11,615 | | | Operating Expenses | | Research Development | 3,397 | 3,673 | 3,801 | 3,639 | | Selling General and Administrative | 7,658 | 8,127 | 9,429 | 11,449 | | Non Recurring | 1,973 | 639 | 166 | 1,244 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,616) | (3,407) | (2,781) | (4,717) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 161 | 29 | (212) | | Earnings Before Interest And Taxes | (6,567) | (3,246) | (2,752) | (4,929) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (6,567) | (3,246) | (2,752) | (4,929) | | Income Tax Expense | 173 | 88 | 58 | (246) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,740) | (3,334) | (2,810) | (4,683) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,740) | (3,334) | (2,810) | (4,683) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,740) | ($3,334) | ($2,810) | ($4,683) |
|
1.52% Nasdaq 
Income Statement
